Christoph Lange

Latest

• Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
• Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis
• Availability and costs of medicines for the treatment of tuberculosis in Europe
• Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
• Pathogen-free diagnosis of tuberculosis
• Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.
• Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
• The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.
• Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries
• Relapse-free cure from multidrug-resistant tuberculosis in Germany
• Time to revise WHO-recommended definitions of MDR-TB treatment outcomes
• Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria
• Treatment outcomes of MDR-TB and HIV co-infection in Europe
• Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure
• Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
• Treatment Outcomes in Multidrug-Resistant Tuberculosis
• Viral Load and Risk of Tuberculosis in HIV Infection
• More on Treatment Outcomes in Multidrug-Resistant Tuberculosis
• Numbers needed to treat to prevent tuberculosis
• Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey
• Multidrug-resistant tuberculosis in europe, 2010-2011
• Risk assessment of tuberculosis in immunocompromised patients. A TBNET study
• Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement